A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico

Soto‐Pérez‐de‐Celis, Enrique; Kim, Heeyoung; Rojo‐Castillo, Maria Patricia; Sun, Can‐Lan; Chávarri‐Guerra, Yanin; Navarrete‐Reyes, Ana Patricia; Waisman, James; Ávila-Funes, José Alberto; Aguayo, Álvaro; Hurria, Arti

doi:10.1016/j.jgo.2017.09.008

Cited by 35 publications

(27 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While ten of the studies were randomized, for obvious reasons none of them were blinded. Education status and familiarity with internet/mobile technology improved outcomes [31] in one study but not in another [26].…”

Section: Methodological Considerationsmentioning

confidence: 74%

“…A review of mHealth applications for patients with cancer in Spain found that only half had been developed by healthcare organisations [48]. The potential lack of clinical input into the development might be one reason for limited clinical impact despite the considerable promise of applications to monitor toxicity [26] or even adjust chemotherapy drug dosing for safety impact [49].…”

Section: Discussionmentioning

confidence: 99%

“…Interventions that were delivered in the studies fell into broad categories: (1) delivery of information/education in a digital format [23][24][25], (2) provision of lifestyle interventions such as mindfulness [19], exercise [26,27] or consumption of vegetables [28] and (3) symptom scores ranging from pain [23] to psychological symptoms of posttraumatic stress disorder (PTSD) [24] and usually linked to a healthcare professional for escalation [29]. One study looking at detection of lung cancer relapse allowed patients to access follow-up and imaging sooner if concern was raised from reported symptoms [30].…”

Section: Interventions Delivered Through Mhealth Applicationsmentioning

confidence: 99%

“…Treatment toxicity A Mexican study established a correlation between reduction in day-to-day mobility and chemotherapy toxicity in geriatric cancer patients [26]. Symptom scores could be used to optimize treatments [31].…”

Section: Reported Outcomesmentioning

confidence: 99%

See 3 more Smart Citations

Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature

Osborn

Ajakaiye

Cooksley

et al. 2019

Support Care Cancer

View full text Add to dashboard Cite

Purpose Patients undergoing systemic anti-cancer treatment experience distressing side effects, and these symptoms are often experienced outside the hospital setting. The impact of usage of cancer-related mobile health (mHealth) applications on patientrelated outcomes requires investigation. Methods A critical appraisal of the literature was performed for the following question: 'In patients with cancer have mHealth applications been compared with usual care to examine impact on commonly used clinical outcomes'. Literature searches were undertaken with the help of a research librarian and included Medline, Cochrane Collaboration, clinical trial databases and grey searches. Results Seventeen studies including between 12 and 2352 patients were identified and reviewed. Smartphone applications or internet portals collected data on symptoms or patient activity. Several studies showed statistically significant differences in patient-reported outcomes when symptom monitoring using mobile health application was compared to usual care. Change in mobility was the only outcome that was related directly to toxicity. Only limited data on mortality, cancer-related morbidity including complications of care, health-economic outcomes or long-term outcomes were reported. Conclusions Studies on mHealth applications might improve aspects of symptom control in patients with cancer, but there is currently little evidence for impact on other outcomes. This requires future research in interventional studies.

show abstract

Section: Methodological Considerationsmentioning

confidence: 74%

Section: Discussionmentioning

confidence: 99%

Section: Interventions Delivered Through Mhealth Applicationsmentioning

confidence: 99%

Section: Reported Outcomesmentioning

confidence: 99%

See 2 more Smart Citations

Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature

Osborn

Ajakaiye

Cooksley

et al. 2019

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…blood glucose levels, oxygen saturation) has been implemented to varying levels of success in a variety of clinical settings, including chronic respiratory disease, diabetes mellitus, diseases affecting mobility, perioperative care and psychiatric conditions. [19][20][21][22][23][24][25][26][27][28][29][30][31] Telemedicine can be used to supplement a Patient-Centred Care approach to management of cirrhosis. The American Association for the Study of Liver Diseases have recently outlined the importance individualising the care provided to cirrhotic patients, while also empowering patients to become more involved in their management.…”

Section: Discussionmentioning

confidence: 99%

Development of a Smartphone Application to Enable Remote Monitoring in the Outpatient Management of Cirrhotic Ascites

Warner

O'neil

et al. 2018

J Int Soc Telemed eHealth

View full text Add to dashboard Cite

Patients who develop hepatic decompensation with ascites have a poor prognosis and often experience other complications including spontaneous bacterial peritonitis, hepatic encephalopathy and variceal bleeding. We hypothesised that smartphone (SP)-enabled remote monitoring of patients with ascites may enable early detection of infection and acute decompensation, facilitate timely intervention and improve patient outcomes. Aim: We aimed to design, develop and implement a remote monitoring system (RMS) for outpatients with cirrhotic ascites. Method: We undertook surveys with patients and hepatologists to quantify the demand for a RMS and identify issues regarding implementation. A smartphone and a web-based application were developed as a RMS. Patients used the RMS in a 6-week prospective non-randomised trial. Results: We surveyed 27 patients (mean age 56 years, 18 (67%) were male, 16 (59%) had Childs Pugh B cirrhosis, and 20 (74%) had a history of alcoholic liver disease) and 5 hepatologists. There were 19 patients (70%) who reported that they would use a RMS. The RMS was used by 10 patients for a mean 53.8days (11-70), who entered 20.6 (0-71) updates. A total of 18 automated alerts occurred. 22% of automated alerts resulted in clinically significant changes to management, such as inpatient admission n=1 (6%), early outpatient appointment n=1 (6%) and reinforced adherence n=2 (11%). Conclusion: We have successfully designed an internet-enabled RMS for outpatients with cirrhotic ascites that could be used as an adjunct to existing outpatient services. Future studies will optimise the alert thresholds, assess long-term patient adoption and quantify clinical impact.

show abstract

Advances in the Functional Assessment of Patients with Sarcoma

Ramsey

Gundle

2020

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico

Cited by 35 publications

References 32 publications

Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature

Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature

Development of a Smartphone Application to Enable Remote Monitoring in the Outpatient Management of Cirrhotic Ascites

Advances in the Functional Assessment of Patients with Sarcoma

Contact Info

Product

Resources

About